US Food & Drug Administration approves treatment for patients with rare bone marrow disorder

16Aug - by Editor - 0 - In STL.News

Silver Spring, MD (STL.News) – Today, the U.S. Food and Drug Administration approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis.

“Prior to today, there was one FDA-approved drug to treat patients with myelofibrosis, a rare bone marrow disorder.  Our approval today provides another option for patients,” said Richard Pazdur, M.D., director of the FDA’s Oncology Center of Excellence and acting director of the Office of Hematology and Oncology Products in the FDA’s Center for Drug Evaluation and Research. 

Continue reading US Food & Drug Administration approves treatment for patients with rare bone marrow disorder at STL.News.

Source link